We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA OKs Label Change for Victoza Showing Efficacy Boost Over Januvia
FDA OKs Label Change for Victoza Showing Efficacy Boost Over Januvia
April 13, 2012
The FDA has approved an update to the U.S. label for Novo Nordisk’s diabetes drug Victoza to include data showing superior blood sugar and weight control compared with Merck’s Januvia.